FIELD: medicine, veterinary science.
SUBSTANCE: invention concerns veterinary science. The invention discloses administration of Arg-Pro-Gly-Pro tetrapeptide as an agent for prevention and treatment of viral diseases. A pharmaceutical composition for prevention and treatment of viral diseases contains an aqueous solution of Arg-Pro-Gly-Pro tetrapeptide in concentration 0.1-1 % and Nipagin in a certain relation of ingredients. A method for prevention of viral diseases involves intranasal, oral or intraperitoneal introduction of said pharmaceutical composition in a dose 0.2-5 mg a day per a mouse for 2 days. A method for treatment of viral diseases involves intranasal, oral or intraperitoneal introduction of said pharmaceutical composition in a dose 0.2-5 mg a day per a mouse for 3 days.
EFFECT: invention enables extending the range of antiviral drugs, providing higher clinical and preventive effectiveness in viral infections, reducing drug cost.
4 cl, 4 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION OF ANTIVIRAL PREPARATION AND METHOD FOR PREVENTION AND TREATMENT OF VIRAL DISEASES BY THIS PREPARATION | 2009 |
|
RU2429875C2 |
| AGENT FOR VIRUS DISEASES PREVENTION AND TREATMENT AND METHOD OF VIRUS DISEASES PREVENTION AND TREATMENT | 2007 |
|
RU2337703C1 |
| AGENT RAISING SURVIVAL AND ALLEVIATING THE COURSE OF VIRAL INFECTION - EXTROMELIA IN EXPERIMENT | 1992 |
|
RU2043115C1 |
| AGENT POSSESSING BIOCIDAL ACTION | 2017 |
|
RU2673807C2 |
| ANTI-VIRAL IMMUNOTROPIC AGENT FOR TREATMENT OF ARVI | 2018 |
|
RU2672888C1 |
| AGENT FOR TREATMENT AND PROPHYLAXIS OF VIRAL TICK-BORNE ENCEPHALITIS INDUCED IN THE EXPERIMENT | 1986 |
|
RU2025126C1 |
| HUMANIZED MONOCLONAL ANTIBODY SPECIFICALLY BINDING TO RBD S OF THE PROTEIN OF THE SARS-COV-2 VIRUS, AGENT AND METHOD FOR THERAPY AND EMERGENCY PREVENTION OF DISEASES CAUSED BY SARS-COV-2 VIRUS | 2021 |
|
RU2765731C1 |
| APPLICATION OF Thr-Lys-Pro-Arg-Pro-Gly-Pro PEPTIDE (SELANK) FOR TOXIC HEPATITIS PREVENTION AND TREATMENT | 2017 |
|
RU2640133C1 |
| APPLICATION OF THR-LYS-PRO-ARG-PRO-GLY-PRO PEPTIDE (SELANK) FOR HEPATOPROTECTIVE IMPACT IN CHRONIC EMOTIONAL-PAIN STRESS | 2016 |
|
RU2629832C1 |
| APPLICATION OF Pro-Gly-Pro-Leu TETRAPEPTIDE AS AGENT FOR PREVENTION AND TREATMENT OF DIABETES, METHOD FOR PREVENTION AND TREATMENT OF DIABETES AND PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF DIABETES | 2008 |
|
RU2378005C1 |
